Stock PSNL PERSONALIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Personalis, Inc.

Equities

PSNL

US71535D1063

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
1.36 USD +7.51% Intraday chart for Personalis, Inc. +7.94% -35.24%
03-26 Personalis, Inc. Announces Publication Validating Next Personal Test for Ultra-Sensitive MRD Detection and Cancer Treatment Response Monitoring CI
02-29 Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Personalis to Announce First Quarter 2024 Financial Results
BU
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
BU
Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
BU
Personalis Announces Publication Validating NeXT Personal Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
AQ
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
BU
Personalis, Inc. Announces Publication Validating Next Personal Test for Ultra-Sensitive MRD Detection and Cancer Treatment Response Monitoring
CI
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating
MT
Personalis: Q4 Earnings Snapshot
AQ
Transcript : Personalis, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Personalis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (PSNL) PERSONALIS Reports Q4 Revenue $19.7M, vs. Street Est of $19.3M
MT
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
BU
Personalis, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024
CI
Personalis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
BU
Personalis to Participate at Upcoming Investor Conferences
BU
Personalis to Offer ClearNote's Epigenomic Platform in Partnership
MT
Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSNL Stock
  4. News Personalis, Inc.